GBA1 and Parkinson disease: The relative abundance of the direct substrate of the β-glucocerebrosidase enzyme, glucosylceramide, was significantly increased and the sphingomyelin fraction (a key downstream metabolite) was reduced in CSF of GBA-PD patients.